RxDoctor Payments Data

Matthew Lipp, MD

Interventional Pain Medicine · Chatham, NJNPI 1649242868

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $60,510 of the $67,408 with a category attached, or 89.8%. Globus Medical accounts for 89.8% of it on its own, with 2 other manufacturers making up the rest. Among interventional pain medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,408in general payments, 2019–2025

Across 34 payments — averaging $1982.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$61K
  • Medtronic$7K
  • Nevro Corp.$33

What the payments were for

  • Royalty or licence$60,51090%
  • Speaking & faculty fees$6,43510%
  • Food & beverage$4631%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Globus Medical24$60,510
Medtronic(2 entities)9$6,864
Nevro Corp.1$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,408 in reported general payments places this provider in the 95th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$337,245
Medicare patients
648
Services billed
2,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate28$36,231
OxycontinOxycodone Hcl25$26,335
Oxycodone Hcl527$10,651
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen321$6,694
Fentanyl35$3,823
Gabapentin374$3,781
Morphine Sulfate ErMorphine Sulfate112$3,534
Celecoxib123$3,027
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen153$2,901
Pregabalin224$2,864
Hydromorphone Hcl95$2,829
Morphine Sulfate54$2,404
Calcitonin-SalmonCalcitonin,salmon,synthetic15$1,746
Tramadol Hcl203$1,668
Lidocaine24$1,474

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Chatham

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →